Lisata Therapeutics, Inc.
LSTA· Nasdaq
LSTALisata Therapeutics, Inc.
Released Mar 17, 2017, after the close
10-K filed Mar 17, 2017, 76 days after period end · 0000320017-17-000008
derived · Computed from the longer spans the company filed.
| Metric | Q4 2015dderived from reported figures | Q4 2014 | Q4 2013 | Q4 2012 |
|---|---|---|---|---|
| Revenue | $10.18M | $7.56K | $5.28K | — |
| Net Income | -$5.44M | -$33.20K | -$11.61K | -$12.54K |
Lisata Therapeutics, Inc. · CIK 320017 · Engraved from SEC EDGAR
| EPS Diluted | — | -$0.59 | -$0.32 | -$0.47 |
|---|
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
